DYSKERATOSIS CONGENITA-TWO SIBLINGS WITH A NEW MISSENSE MUTATION IN THE DKC1 GENE

被引:6
|
作者
Coelho, Joana Dias [1 ]
Lestre, Sara [1 ]
Kay, Teresa [2 ]
Paiva Lopes, Maria Joao [1 ]
Fiadeiro, Teresa [1 ]
Apetato, Margarida [1 ]
机构
[1] Ctr Hosp Lisboa Cent, Dept Dermatol, Lisbon, Portugal
[2] Ctr Hosp Lisboa Cent, Dept Genet, Lisbon, Portugal
关键词
D O I
10.1111/j.1525-1470.2010.01299.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Dyskeratosis congenital is reported in two siblings. They presented with the classic triad of mucocutaneous features: leukoplakia of the tongue, dystrophic nails, and a widespread reticulate pigmentation on the neck and upper chest. A genetic analysis was performed and a new missense mutation S356P, hemizygous, was identified in the DKC1 gene in both patients. Acitretin was started at a low-dose in both patients, resulting in clinical improvement and important, positive psychosocial effects.
引用
收藏
页码:464 / 466
页数:4
相关论文
共 50 条
  • [31] A novel DKC1 gene mutation c.1177 A>T (p.I393F) in a case of dyskeratosis congenita with severe telomere shortening
    Mohanty, Purvi
    Jadhav, Prajakta
    Shanmukhaiah, Chandrakala
    Kumar, Selvaa
    Vundinti, Babu Rao
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2019, 58 (12) : 1468 - 1471
  • [32] Generation of dyskeratosis congenita-like hematopoietic stem cells through the stable inhibition of DKC1
    Carlos Carrascoso-Rubio
    Hidde A. Zittersteijn
    Laura Pintado-Berninches
    Beatriz Fernández-Varas
    M. Luz Lozano
    Cristina Manguan-Garcia
    Leandro Sastre
    Juan A. Bueren
    Rosario Perona
    Guillermo Guenechea
    Stem Cell Research & Therapy, 12
  • [33] Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1
    Knight, SW
    Heiss, NS
    Vulliamy, TJ
    Aalfs, CM
    McMahon, C
    Richmond, P
    Jones, A
    Hennekam, RCM
    Poustka, A
    Mason, PJ
    Dokal, I
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (02) : 335 - 339
  • [34] High resolution melting analysis for the identification of novel mutations in DKC1 and TERT genes in patients with dyskeratosis congenita
    Carrillo, J.
    Martinez, P.
    Solera, J.
    Moratilla, C.
    Gonzalez, A.
    Manguan-Garcia, C.
    Aymerich, M.
    Canal, L.
    del Campo, M.
    Dapena, J. L.
    Escoda, L.
    Garcia-Sagredo, J. M.
    Martin-Sala, S.
    Rives, S.
    Sevilla, J.
    Sastre, L.
    Perona, R.
    BLOOD CELLS MOLECULES AND DISEASES, 2012, 49 (3-4) : 140 - 146
  • [35] Case Report: A Missense Mutation in Dyskeratosis Congenita 1 Leads to a Benign Form of Dyskeratosis Congenita Syndrome With the Mucocutaneous Triad
    Wang, Liqing
    Li, Jianwei
    Xiong, Qiuhong
    Zhou, Yong-An
    Li, Ping
    Wu, Changxin
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [36] Dyskeratosis congenita with a new Mutation
    Hennes, E.
    Dueckers, G.
    Niehues, T.
    Assaf, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 127 - 127
  • [37] Mutations in X-linked dyskeratosis congenita (DC) gene (DKC1) only account for ∼50% of families:: Further evidence for additional DC gene(s).
    Vulliamy, TJ
    Knight, SW
    Mason, PJ
    Dokal, I
    BLOOD, 1999, 94 (10) : 674A - 674A
  • [38] Phenotypic Rescue Of Induced Pluripotent Stem Cells From Dyskeratosis Congenita Patients By Ectopic Expression Of DKC1 But Not TERC
    Gu, Bai-wei
    Mills, Jason A.
    Apicella, Marisa
    Fan, Jian-meng
    French, Deborah L.
    Bessler, Monica
    Mason, Philip J.
    BLOOD, 2013, 122 (21)
  • [39] Mapping and characterization of the X-linked dyskeratosis congenita (DKC) gene
    Hassock, S
    Vetrie, D
    Giannelli, F
    GENOMICS, 1999, 55 (01) : 21 - 27
  • [40] Defects in mTR stability and telomerase activity produced by the Dkc1 A353V mutation in dyskeratosis congenita are rescued by a peptide from the dyskerin TruB domain
    Machado-Pinilla, Rosario
    Carrillo, Jaime
    Manguan-Garcia, Cristina
    Sastre, Leandro
    Mentzer, Alexander
    Gu, B. -W.
    Mason, Philip J.
    Perona, Rosario
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (10): : 755 - 763